Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 6/20 | 1.00 |
| ▸ | PTPN7 | P35236 | 4/20 | 0.85 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.65 |
| ▸ | RECQL | P46063 | 1/20 | 0.65 |
| ▸ | PPARG | P37231 | 6/20 | 0.61 |
| ▸ | PPARD | Q03181 | 6/20 | 0.61 |
| ▸ | PPARA | Q07869 | 6/20 | 0.61 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.61 |
| ▸ | TSHR | P16473 | 4/20 | 0.61 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | TLR2 | O60603 | 2/20 | 0.61 |
| ▸ | FABP4 | P15090 | 2/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.61 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.61 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | ESR1 | P03372 | 1/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | PDE4A | P27815 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13591747 | 1.00 | HMGCR (1.00) | HMGCRPTPN7TDP1RECQLPPARG | |
| SCHEMBL3665801 | 1.00 | HMGCR (1.00) | HMGCRPTPN7TDP1RECQLPPARG | |
| SCHEMBL31238072 | 0.98 | HMGCR (0.96) | HMGCRPTPN7TDP1RECQLPPARG | |
| SCHEMBL416143 | 0.96 | HMGCR (1.00) | HMGCRPTPN7TDP1RECQLPPARG | |
| SCHEMBL417934 | 0.96 | HMGCR (1.00) | HMGCRPTPN7TDP1RECQLPPARG | |
| Stearic Acid SCHEMBL10942937 | 0.96 | HMGCR (1.00) | HMGCRPTPN7TDP1RECQLPPARG | |
| SCHEMBL12478231 | 0.96 | HMGCR (1.00) | HMGCRPTPN7TDP1RECQLPPARG | |
| SCHEMBL455799 | 0.96 | HMGCR (1.00) | HMGCRPTPN7TDP1RECQLPPARG | |
| SCHEMBL3673938 | 0.96 | HMGCR (1.00) | HMGCRPTPN7TDP1RECQLPPARG | |
| SCHEMBL3667270 | 0.96 | HMGCR (1.00) | HMGCRPTPN7TDP1RECQLPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116042210-A | Quantum dot capable of being directly photoetched, preparation method and application thereof | 宁波杭州湾新材料研究院 | 2023-05-02 | — | — | CN | claimed |
| US-9163307-B2 | Three-dimensional photoresists via functionalization of polymer thin films fabricated by iCVD | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2015-10-20 | — | — | US | claimed |
| US-20130260054-A1 | Three-Dimensional Photoresists via Functionalization of Polymer Thin Films Fabricated by iCVD | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2013-10-03 | — | — | US | claimed |
| WO-2013148126-A1 | THREE-DIMENSIONAL PHOTORESISTS VIA FUNCTIONALIZATION OF POLYMER THIN FILMS FABRICATED BY ICVD | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2013-10-03 | — | — | WO | claimed |
| WO-2010089545-A1 | ENCAPSULATED NANOPARTICLES | NANOCO TECHNOLOGIES LTD (GB) | 2010-08-12 | — | — | WO | claimed |
| US-20100193767-A1 | ENCAPSULATED NANOPARTICLES | NANOCO TECHNOLOGIES LIMITED (GB) | 2010-08-05 | — | — | US | claimed |
| US-20260124154-A1 | LIPID NANOPARTICLE LYOPHILIZED COMPOSITION | NOF CORPORATION (JP) | 2026-05-07 | — | — | US | disclosed |
| US-20240423086-A1 | LIGHT-EMITTING ELEMENT AND METHOD FOR PRODUCING SAME | Sharp Display Technology Corporation (JP) | 2024-12-19 | — | — | US | disclosed |
| CN-114536885-A | Packaging material containing indicator responsive to external stimulus | 洲际大品牌有限责任公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-110945351-A | Packaging material containing indicator responsive to external stimulus | 洲际大品牌有限责任公司 | 2020-03-31 | — | — | CN | disclosed |
| CN-110914889-A | Inkless printing on substrates and food | 洲际大品牌有限责任公司 | 2020-03-24 | — | — | CN | disclosed |
| US-20170167033-A1 | ETCHING AGENT AND REPLENISHING LIQUID | MEC COMPANY LTD. (JP) | 2017-06-15 | — | — | US | disclosed |
| EP-3168328-A1 | ETCHING AGENT AND REPLENISHING LIQUID | MEC COMPANY LTD. (JP) | 2017-05-17 | — | — | EP | disclosed |
| US-9163307-B2 | Three-dimensional photoresists via functionalization of polymer thin films fabricated by iCVD | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2015-10-20 | — | — | US | disclosed |
| US-20130260054-A1 | Three-Dimensional Photoresists via Functionalization of Polymer Thin Films Fabricated by iCVD | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2013-10-03 | — | — | US | disclosed |
| WO-2013148126-A1 | THREE-DIMENSIONAL PHOTORESISTS VIA FUNCTIONALIZATION OF POLYMER THIN FILMS FABRICATED BY ICVD | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2013-10-03 | — | — | WO | disclosed |
| WO-2010089545-A1 | ENCAPSULATED NANOPARTICLES | NANOCO TECHNOLOGIES LTD (GB) | 2010-08-12 | — | — | WO | disclosed |
| US-20100193767-A1 | ENCAPSULATED NANOPARTICLES | NANOCO TECHNOLOGIES LIMITED (GB) | 2010-08-05 | — | — | US | disclosed |
| EP-1091958-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000001692-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2000-01-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260124154-A1 | LIPID NANOPARTICLE LYOPHILIZED COMPOSITION | PHOSPHO1, PLTP, APOL1 | HMGCR 624/4885PTPN7 2307/4885TDP1 1589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.